Clinical Trial Update: RAD001 and Lenalidomide in the Treatment of Subjects With Relapsed and Relapsed/Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating RAD001 (everolimus) in combination with lenalidomide in subjects with relapsed and relapsed/refractory multiple myeloma; the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)
• RAD001 (everolimus)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED